Thu, Nov 27, 2014, 1:26 PM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Intercept Pharmaceuticals, Inc. Message Board

  • moneyandstocks moneyandstocks Aug 15, 2014 10:45 AM Flag

    The total market for a treatment of NASH is estimated to be over $30 billion. LINK

    Bidness Etc.
    8/14/14
    investors look to capitalize on a potential gold mine
    Intercept has worldwide rights to Obeticholic acid (OCA), which is a multibillion dollar drug if it successfully completes Phase 3 trials for treating Nonalcoholic Steatohepatitis (NASH), for currently there is no treatment for the disease. The total market for a treatment of NASH is estimated to be over $30 billion.

 
ICPT
150.45+1.25(+0.84%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.